Atheroklefit, drops, 100 ml

Name: Atheroklefit, drops, 100 ml
SKU: 225821
Availability: InStock

€9.55

EAN: 4602242003250 SKU: 225821 Categories: Cardiovascular, Medicine

Description

Pharmacotherapeutic group

Hypolipidemic drug of plant origin

ATC code: C10AX

Pharmacological properties

Pharmacodynamics

p> Atheroklefit^® is a liquid extract from the red clover grass collected during the flowering phase. The extract is obtained by double extraction of red clover grass with 40% ethanol.

According to preclinical studies, the liquid extract of red clover herb has moderate hypolipidemic effect: it helps to decrease the concentration of total cholesterol, concentration of low-density lipoproteins (LDL) and increase the concentration of high-density lipoproteins (HDL).

The mechanism of action of the liquid extract of red clover herb is associated with a redistribution of cholesterol from LDL to HDL, in which cholesterol is more quickly metabolized and eliminated from the body.

The liquid extract of the herb clover red also helps reduce the intensity of lipid peroxidation, resulting in reduced lipoprotein peroxidation and normalizes the permeability of the vascular wall.

Pharmacokinetics

There are no data available.

Indications
Indications
Hyperlipidemia type Ia according to Frederickson, mild.

Active ingredient
Active ingredient

Composition
Composition
To obtain 1000 ml of the drug, use:
The active ingredient:
Clover grass – 500 g
Associate:
Ethanol (ethyl alcohol) 40% – sufficient amount to obtain 1000 ml of the drug.

How to take, the dosage
How to take, the dosage
Internal: 1 teaspoon of the drug, pre-diluted in 1/3 cup of water, 3 times a day for 30 minutes before a meal. The course of treatment is 3-6 months. The repeated course of treatment is possible by a doctor’s recommendation.
Before the drug administration the patient should be put on a hypocholesterolemic diet, which must be continued during the whole therapy period.

Interaction
Interaction

Special Instructions
Special Instructions
Consult with the attending physician before starting the use of the drug.
Hypatic transaminases, creatine phosphokinase activity, and renal function control are required during therapy with AteroclefitÂ®.
To this end, it is recommended to visit a doctor at least once a month during therapy with AteroclefitÂ® in order to adjust therapy, if necessary. The frequency and timing of these visits is determined by the attending physician.
The ethanol content of the drug is at least 35%. A single dose of the drug (1 teaspoon) contains 1.58 g of absolute ethanol, the maximum daily dose (3 teaspoons) contains 4.74 g of absolute ethanol.
The indicated daily dose should not be exceeded.
Women of childbearing age should use reliable contraceptive methods when using the drug.
Impact on ability to drive vehicles, machinery
When using AterolefitÂ® , one should refrain from driving vehicles and engaging in other potentially dangerous activities requiring increased concentration and quick psychomotor reactions.

Contraindications
Contraindications
Hypersensitivity to the components of the drug; age under 18 years, brain injury, brain disease, liver disease, marked renal dysfunction, alcoholism (due to the presence of ethanol).
Put patients with renal dysfunction of mild to moderate degree of caution.
Persons with chronic diseases should consult a physician before using the drug.

Side effects
Side effects
Internal: 1 teaspoon of the drug, pre-diluted in 1/3 cup of water, 3 times a day for 30 minutes before a meal. The course of treatment is 3-6 months. The repeated course of treatment is possible by a doctor’s recommendation.
Before the drug administration the patient should be put on a hypocholesterolemic diet, which must be continued during the whole therapy period.

Overdose
Overdose

Pregnancy use
Pregnancy use

Additional information
Weight 0.212 kg
Shelf life
2 years.
Conditions of storage
At a temperature not exceeding 25 ºC.
Manufacturer
Evalar, Russia
Medication form
oral drops
Brand
Evalar